Home › Funds › Split Creek LLC DBA Split Creek Capital LLC › ABT

Split Creek LLC DBA Split Creek Capital LLC position in ABT

ABBOTT LABORATORIES · Health Care

Split Creek LLC DBA Split Creek Capital LLC reported holding 10,609 shares of ABT (ABBOTT LABORATORIES) in its Q3 2026 13F filing — a position valued at US$1.0M, representing 0.99% of its reported portfolio and ranking #26 among its reported holdings. Split Creek LLC DBA Split Creek Capital LLC has disclosed ABT holdings in 4 of the last 4 reported quarters, going back to Q4 2025.

Latest position (Q3 2026)10.61K sh
Reported value held$1.05M
Portfolio Weight0.99%
First reportedQ4 2025
Last changeReduce
Updated2026-11-02

Last updated: 2026-11-02 · Source: SEC EDGAR Form 13F-HR

How Split Creek LLC DBA Split Creek Capital LLC's ABT position evolved

Split Creek LLC DBA Split Creek Capital LLC first disclosed a stake in ABT in Q4 2025 at 11,387 shares (US$1.4M). Across 4 filings, Split Creek LLC DBA Split Creek Capital LLC increased the stake 2 time(s), trimmed it 1 time(s) and left it unchanged 0 time(s). The most recent filing (Q3 2026) shows 10,609 shares valued at US$1.0M — a reduction of -1,312 shares quarter over quarter..

Quarter by quarter

QuarterSharesValueChange
Q4 2025 11.39K $1.43M New
Q1 2026 11.56K $1.19M Add
Q2 2026 11.92K $1.08M Add
Q3 2026 10.61K $1.05M Reduce

Dots on the line are colored by change type; missing quarters mean no position was reported.

About ABT and 13F data

ABT (ABBOTT LABORATORIES) is a Health Care company. 20 other funds we track also report a position in ABT — the largest reported positions include Vanguard Group (US$22.00B), Charles Schwab Investment Management (US$5.41B), CHARLES SCHWAB INVESTMENT MANAGEMENT INC (US$5.41B). Under SEC rules, institutional investment managers with over $100M in assets must file Form 13F within 45 days of each quarter-end, disclosing long positions in US-listed equities. The data excludes short positions, most options and foreign holdings, so treat it as a quarterly snapshot rather than a live position.

Other funds holding ABT

All ABT fund holders →

FAQ

How long has Split Creek LLC DBA Split Creek Capital LLC held ABT?

Split Creek LLC DBA Split Creek Capital LLC has disclosed ABT holdings in 4 of the last 4 reported quarters, going back to Q4 2025.

What is Split Creek LLC DBA Split Creek Capital LLC's current position in ABT?

As of Q3 2026, Split Creek LLC DBA Split Creek Capital LLC holds 10.61K shares of ABT (ABBOTT LABORATORIES), valued at $1.05M, representing 0.99% of its reported portfolio and ranking #26.

Has Split Creek LLC DBA Split Creek Capital LLC been buying or selling ABT?

In the latest 13F filing (Q3 2026), Split Creek LLC DBA Split Creek Capital LLC reduced its position in ABT.

Which other funds hold ABT?

Other major institutional holders of ABT include Vanguard Group, Charles Schwab Investment Management, CHARLES SCHWAB INVESTMENT MANAGEMENT INC, among 20 funds with disclosed positions.

Where does this data come from?

All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.